Ccl5 is a broader activator of several chemokine receptors, including Ccr1, Ccr3, Ccr4 and Ccr5 and it has been claimed as an important player in the pathophysiology of NAFLD-progression77. The gene discussed is CCR3; the disease is metabolic dysfunction-associated steatotic liver disease.